In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark
The company also plans to register the similar range of products in the neighbouring countries.
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS
The vaccine was 85 percent effective in preventing severe disease across all regions.
The price increases are due to the rising costs of raw materials.
The partnership is a significant step in delivering advanced cancer therapies to patients.
With cost optimization leading to cumulative savings of US $80 million over last 8 years, the company now aims to tap bigger opportunities in generics business
Subscribe To Our Newsletter & Stay Updated
